Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial

BACKGROUND: Type 2 circulating vaccine-derived polioviruses (cVDPV2) from Sabin oral poliovirus vaccines (OPVs) are the leading cause of poliomyelitis. A novel type 2 OPV (nOPV2) has been developed to be more genetically stable with similar tolerability and immunogenicity to that of Sabin type 2 vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Khaelqu, Bandyopadhyay, Ananda S, Hoque, Masuma, Gast, Christopher, Yunus, Mohammad, Jamil, Khondoker M, Mainou, Bernardo A, Konopka-Anstadt, Jennifer L, Hendley, William S, Vincent, Annelet, Clemens, Ralf, Clemens, Sue Ann Costa, Ross, Allen G, Clemens, John D, Tritama, Erman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860215/
https://www.ncbi.nlm.nih.gov/pubmed/36495882
http://dx.doi.org/10.1016/S0140-6736(22)02397-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860215/
https://www.ncbi.nlm.nih.gov/pubmed/36495882
http://dx.doi.org/10.1016/S0140-6736(22)02397-2

Ejemplares similares